Send us Feedback

ONYX Pharmaceuticals (ONXX)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Income Statement    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Total Revenue 72.0M 72.7M 89.5M 128M 145M
Cost of Revenue 0 0 496K 832K 1.97M
Gross Profit 72.0M 72.7M 89.0M 127M 144M
Research & Development 80.7M 76.4M 85.7M 82.6M 91.3M
SG&A 38.9M 102M 71.6M 8.33M 72.5M
Amortization & Deprec 0 0 8.22M 10.4M 10.4M
Other Expenses 3.18M 430K -4.11M -7.90M -2.29M
Total Operating Expenses 123M 179M 161M 93.4M 172M
Operating Income -50.8M -106M -72.4M 33.6M -28.5M
Other Income -147K 5.08M -569K -71.9M 446K
EBIT -50.9M -101M -72.9M -38.3M -28.0M
Minority Interest 0 0 0 0 0
Interest Expense 5.30M 4.94M 5.46M 5.66M 5.63M
Income Before Taxes -56.2M -106M -78.4M -43.9M -33.7M
Income Taxes 18.0K -15.0K -95.8M -1.00M 18.0K
Net Income from Continuing Ops -56.2M -106M 17.4M -42.9M -33.7M
Income - Discontinued Ops 0 0 0 0 0
Extraordinary Items 0 0 0 0 0
Effect of Accounting Changes 0 0 0 0 0
Other Items 0 0 0 0 0
Net Income -56.2M -106M 17.4M -42.9M -33.7M
Preferred Dividends 0 0 0 0 0
Net Income to Common -56.2M -106M 17.4M -42.9M -33.7M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki